The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients
Status:
Completed
Trial end date:
2020-09-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to validate the novel hypothesis that daily use of L-cysteine
(Acetium® capsules) is an effective means to decrease the frequency of (or completely abort)
the headache attacks in migraine patients.
Phase:
N/A
Details
Lead Sponsor:
Biohit Oyj
Collaborator:
The Finnish Funding Agency for Technology and Innovation (TEKES)